<?xml version="1.0" encoding="UTF-8"?>
<p id="Par89">In Myeloma X, 60% achieved VGPR response or better after ASCT. A total of 91 participants are required in each arm to detect an increase of 20% (from 60 to 80%) in ≥ VGPR rate in the ASCT
 <sub>Aug</sub> arm with 80% power at the two-sided 5% significance level [
 <xref ref-type="bibr" rid="CR21">21</xref>] for first randomisation (R1).
</p>
